AU Patent

AU2004274212B2 — Dimethoxy docetaxel acetone solvate et method for the preparation thereof

Assigned to Aventis Pharma SA · Expires 2010-03-04 · 16y expired

What this patent protects

Patent listed against Jevtana Kit.

Drugs covered by this patent

Jevtana Kit (cabazitaxel) · Accord Hlthcare

Patent Metadata

Patent number: AU2004274212B2
Jurisdiction: AU
Classification: —
Expires: 2010-03-04
Drug substance claim: No
Drug product claim: No
Assignee: Aventis Pharma SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.